IP Library Granted Patent US 10,327,846
Granted Patent B1
US 10,327,846 · App. 15/246,815 · Granted Jun 25, 2019

Methods for treating vascular stenoses including laser atherectomy and drug delivery via drug-coated balloons

Inventors: Matthew Stark (Castle Rock, CO); Diane Gorder (Monument, CO); Timothy J. Hale (Castle Rock, CO); Blaine Schneider (Colorado Springs, CO)
Assignee: THE SPECTRANETICS CORPORATION
A61B18/245A61L29/08A61L29/16A61M25/104A61B2018/00172A61B2018/00267A61B2018/00345A61B2018/00577A61B2018/2261A61B2018/2266A61L2300/416A61L2300/606A61M2025/105
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,327,846
App. No.
15/246,815
Granted
Jun 25, 2019
Kind
B1
Abstract

A method for treating a stenosis includes providing a laser ablation system including a laser catheter, the laser catheter including a distal end having a plurality of laser emitters; positioning the distal end of the laser catheter within the subject proximate the target vascular portion; delivering laser energy to the laser catheter and emitting the laser energy from the plurality of laser emitters to ablate the stenosis; withdrawing the laser catheter from the subject; providing a balloon system including a drug-coated balloon, the balloon carrying at least one therapeutic agent, the therapeutic agent being a restenosis inhibitor; positioning the balloon within the subject proximate the target vascular portion; expanding the balloon to engage the target vascular portion; delivering the therapeutic agent from the balloon to the target vascular portion; delivering the therapeutic agent from the balloon to the target vascular portion; and withdrawing the balloon from the subject.

Claims (50)

1. A method for treating a target vascular portion of a subject including a stenosis, the method comprising:

providing a laser ablation system including a laser catheter, the laser catheter including a distal end having a plurality of laser emitters;

positioning the distal end of the laser catheter within the subject proximate the target vascular portion;

delivering laser energy to the laser catheter and emitting the laser energy from the plurality of laser emitters to ablate the stenosis, including:

emitting the laser energy at a first intensity;

emitting the laser energy at a second intensity, the second intensity being different than the first intensity;

withdrawing the laser catheter from the subject;

providing a balloon system including a drug-coated balloon, the drug-coated balloon carrying at least one therapeutic agent, the at least one therapeutic agent being a restenosis inhibitor;

positioning the drug-coated balloon within the subject proximate the target vascular portion;

expanding the drug-coated balloon to engage the target vascular portion;

delivering the at least one therapeutic agent from the drug-coated balloon to the target vascular portion; and

withdrawing the drug-coated balloon from the subject.

2. The method of claim 1 , wherein the restenosis inhibitor includes paclitaxel.

3. The method of claim 1 , wherein the laser ablation system includes a laser generator, and further comprising delivering the laser energy from the laser generator to the laser catheter.

4. The method of claim 1 , wherein the target vascular portion of the subject includes a stent coupled to the stenosis, and wherein emitting the laser energy from the plurality of laser emitters to ablate the stenosis includes emitting the laser energy from the plurality of laser emitters to ablate the stenosis within the stent.

5. The method of claim 1 , wherein the second intensity is greater than the first intensity.

6. The method of claim 1 , wherein emitting the laser energy from the plurality of laser emitters to ablate the stenosis includes:

emitting the laser energy at a first repetition rate; and

emitting the laser energy at a second repetition rate, the second repetition rate being different than the first repetition rate.

7. The method of claim 6 , wherein the second repetition rate is greater than the first repetition rate.

8. A method for treating a target vascular portion of a subject including a stenosis, the method comprising:

providing a laser ablation system including a first laser catheter including a distal end having a first plurality of laser emitters, the first laser catheter having a first external diameter, the laser ablation system further including a second laser catheter including a distal end having a second plurality of laser emitters, the second laser catheter having a second external diameter, the second external diameter being different than the first external diameter;

positioning the distal end of the first laser catheter within the subject proximate the target vascular portion;

delivering laser energy to the first laser catheter and emitting the laser energy from the first plurality of laser emitters to ablate the stenosis;

withdrawing the first laser catheter from the subject;

positioning the distal end of the second laser catheter within the subject proximate the target vascular portion;

delivering laser energy to the second laser catheter and emitting the laser energy from the second plurality of laser emitters to ablate the stenosis;

withdrawing the second laser catheter from the subject;

providing a balloon system including a drug-coated balloon, the drug-coated balloon carrying at least one therapeutic agent, the at least one therapeutic agent being a restenosis inhibitor;

positioning the drug-coated balloon within the subject proximate the target vascular portion;

expanding the drug-coated balloon to engage the target vascular portion;

delivering the at least one therapeutic agent from the drug-coated balloon to the target vascular portion; and

withdrawing the drug-coated balloon from the subject.

9. The method of claim 8 , wherein the second external diameter is greater than the first external diameter.

10. A method for treating a target vascular portion of a subject including a stenosis, the method comprising:

providing a laser ablation system including a laser catheter, the laser catheter including a distal end having a plurality of laser emitters;

positioning the distal end of the laser catheter within the subject proximate the target vascular portion;

delivering laser energy to the laser catheter and emitting the laser energy from the plurality of laser emitters to ablate the stenosis, including:

emitting the laser energy at a first repetition rate;

emitting the laser energy at a second repetition rate, the second repetition rate being different than the first repetition rate;

withdrawing the laser catheter from the subject;

providing a balloon system including a drug-coated balloon, the drug-coated balloon carrying at least one therapeutic agent, the at least one therapeutic agent being a restenosis inhibitor;

positioning the drug-coated balloon within the subject proximate the target vascular portion;

expanding the drug-coated balloon to engage the target vascular portion;

delivering the at least one therapeutic agent from the drug-coated balloon to the target vascular portion; and

withdrawing the drug-coated balloon from the subject.

11. The method of claim 10 , wherein the second repetition rate is greater than the first repetition rate.

12. The method of claim 10 , wherein the restenosis inhibitor includes paclitaxel.

13. The method of claim 10 , wherein the laser ablation system includes a laser generator, and further comprising delivering the laser energy from the laser generator to the laser catheter.

14. The method of claim 10 , wherein the target vascular portion of the subject includes a stent coupled to the stenosis, and wherein emitting the laser energy from the plurality of laser emitters to ablate the stenosis includes emitting the laser energy from the plurality of laser emitters to ablate the stenosis within the stent.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: STARK, MATTHEW; GORDER, DIANE; HALE, TIMOTHY J.; SCHNEIDER, BLAINE
To: THE SPECTRANETICS CORPORATION
Reel/Frame 049334/0872 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
SECURITY INTEREST (TERM) Recorded Jun 13, 2017
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042782/0958 →
SECURITY INTEREST (REVOLVER) Recorded Jun 13, 2017
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042787/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: STARK, MATTHEW; GORDER, DIANE; HALE, TIMOTHY J.; SCHNEIDER, BLAINE
To: THE SPECTRANETICS CORPORATION
Reel/Frame 042577/0235 →
Continuity (1)
Provisional Application 62209691 · Aug 25, 2015
Cited By (8)
US 12,446,961 US 12,533,184 US 12,605,205 US 12,611,253 US 12,653,608 US 12,672,915 US 12,702,479 US 12,708,442